Thorac Cardiovasc Surg
DOI: 10.1055/a-2239-1810
Original Cardiovascular

Comparison between Off-Pump and On-Pump Beating Heart Coronary Artery Bypass Grafting

Kazuki Matsuhashi
1   Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
,
1   Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
,
Atsuo Maekawa
1   Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
,
Koji Yamana
1   Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
,
Kiyotoshi Akita
1   Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
,
Kentaro Amano
1   Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
,
Yasushi Takagi
1   Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
› Author Affiliations

Abstract

Background Although coronary artery bypass grafting (CABG) is performed via three different techniques, conventional, on-pump beating heart CABG (ONBHCAB), or off-pump CABG (OPCAB), data are limited to compare ONBHCAB with OPCAB.

Methods We retrospectively investigated the postoperative cardiac biomarkers, creatine kinase-MB (CK-MB), and troponin I (cTnI), and early and late outcomes in 806 patients undergoing isolated ONBHCAB or OPCAB between February 2008 and September 2022. To eliminate the bias between different groups, propensity score matching was conducted to validate the findings.

Results After matching, the number of each study group totaled 270 patients. In both complete and matched cohorts, early outcomes, including morbidities and mortalities, were similar. However, cTnI and CK-MB levels were significantly higher after ONBHCAB than after OPCAB with median peak cTnI of 9.85 versus 4.60 ng/mL and median peak CK-MB of 48.45 versus 17.10 ng/mL in the matched cohort, which were quite low, below the threshold for values defining perioperative myocardial infarction. At follow-up of 73 ± 45 months, the overall actuarial survival rates were similar between the ONBHCAB and OPCAB patients (86 vs. 87% at 5 years and 64 vs. 68% at 10 years, respectively, in the matched cohort).

Conclusion ONBHCAB may be a comparable alternative to OPCAB with similar early and late outcomes, despite higher elevation of postoperative cardiac biomarkers. ONBHCAB provides more efficient hemodynamic support, providing a better surgical visual field, than OPCAB while reducing the risk of incomplete revascularization.



Publication History

Received: 21 October 2023

Accepted: 02 January 2024

Accepted Manuscript online:
05 January 2024

Article published online:
09 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Shroyer AL, Hattler B, Wagner TH. et al; Veterans Affairs ROOBY-FS Group. Five-year outcomes after on-pump and off-pump coronary-artery bypass. N Engl J Med 2017; 377 (07) 623-632
  • 2 Quin JA, Wagner TH, Hattler B. et al. Ten-year outcomes of off-pump vs on-pump coronary artery bypass grafting in the department of Veterans Affairs: a randomized clinical trial. JAMA Surg 2022; 157 (04) 303-310
  • 3 Izumi Y, Magishi K, Ishikawa N, Kimura F. On-pump beating-heart coronary artery bypass grafting for acute myocardial infarction. Ann Thorac Surg 2006; 81 (02) 573-576
  • 4 Miyahara K, Matsuura A, Takemura H. et al. On-pump beating-heart coronary artery bypass grafting after acute myocardial infarction has lower mortality and morbidity. J Thorac Cardiovasc Surg 2008; 135 (03) 521-526
  • 5 Xia L, Ji Q, Song K. et al. Early clinical outcomes of on-pump beating-heart versus off-pump technique for surgical revascularization in patients with severe left ventricular dysfunction: the experience of a single center. J Cardiothorac Surg 2017; 12 (01) 11
  • 6 Wang W, Wang Y, Piao H. et al. Early and medium outcomes of on-pump beating-heart versus off-pump CABG in patients with moderate left ventricular dysfunction. Rev Bras Cir Cardiovasc 2019; 34 (01) 62-69
  • 7 Chaudhry UA, Harling L, Sepehripour AH. et al. Beating-heart versus conventional on-pump coronary artery bypass grafting: a meta-analysis of clinical outcomes. Ann Thorac Surg 2015; 100 (06) 2251-2260
  • 8 Ueki C, Sakaguchi G, Akimoto T, Ohashi Y, Sato H. On-pump beating-heart technique is associated with lower morbidity and mortality following coronary artery bypass grafting: a meta-analysis. Eur J Cardiothorac Surg 2016; 50 (05) 813-821
  • 9 Thygesen K, Alpert JS, Jaffe AS. et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018; 72 (18) 2231-2264
  • 10 Thielmann M, Sharma V, Al-Attar N. et al. ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery. Eur Heart J 2017; 38 (31) 2392-2407
  • 11 Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 2013; 48 (03) 452-458
  • 12 Takagi H, Mizuno Y, Niwa M, Goto SN, Umemoto T. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A meta-analysis of randomized trials for repeat revascularization following off-pump versus on-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2013; 17 (05) 878-880
  • 13 Jiang Y, Xu L, Liu Y, Deng B, Dong N, Chen S. Beating-heart on-pump coronary artery bypass grafting vs. off-pump coronary artery bypass grafting: a systematic review and meta-analysis. J Thorac Dis 2021; 13 (07) 4185-4194
  • 14 Domanski MJ, Mahaffey K, Hasselblad V. et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 2011; 305 (06) 585-591
  • 15 Mahaffey KW, Roe MT, Kilaru R. et al. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. Eur Heart J 2007; 28 (04) 425-432
  • 16 Petäjä L, Salmenperä M, Pulkki K, Pettilä V. Biochemical injury markers and mortality after coronary artery bypass grafting: a systematic review. Ann Thorac Surg 2009; 87 (06) 1981-1992
  • 17 Devereaux PJ, Lamy A, Chan MTV. et al; VISION Cardiac Surgery Investigators. High-sensitivity troponin I after cardiac surgery and 30-day mortality. N Engl J Med 2022; 386 (09) 827-836
  • 18 Weidenmann V, Robinson NB, Rong LQ. et al. Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: a review. Int J Surg 2020; 79: 76-83
  • 19 De Hert S, Moerman A. Myocardial injury and protection related to cardiopulmonary bypass. Best Pract Res Clin Anaesthesiol 2015; 29 (02) 137-149